Malaria Diagnostics Market Analysis By Technology (Microscopy, Rapid Diagnostic Test, and Others), By Region (Africa, East Mediterranean, America, Europe, South-East Asia, and Western Pacific) And Segment Forecasts To 2022
The malaria diagnostics market was worth USD 579.5 million in 2015 owing to rising prevalence of the disease worldwide. The market is projected to reach USD 789.0 million over the forecast period. In addition to growing need for technological advancements, there is rising demand for cost-efficient and high-quality diagnostics methodologies that can trigger growth in the industry.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Malaria Diagnostics Market - Industry Summary and Key Buying Criteria, 2012 - 2020
CHAPTER 3. MALARIA DIAGNOSTICS INDUSTRY OUTLOOK
3.1. Market segmentation
3.2. Market size and growth prospects, 2012-2020
3.3. Malaria Diagnostics: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing demand for diagnostic tools in malaria endemic countries
3.3.1.2. Development of technically advanced and efficient diagnostics
3.3.2. Market restraint analysis
3.3.2.1. Growth in countries moving towards malaria elimination phase
3.3.2.2. Rising demand for low cost diagnostic tools
3.4. Key opportunities prioritized
3.5. Malaria Diagnostics Industry analysis - Porter's Five Forces Model
3.6. Malaria Diagnostics Market - PESTEL Analysis
3.7. Malaria Diagnostics: Company Market Share Analysis (%), 2014
CHAPTER 4. MALARIA DIAGNOSTICS TECHNOLOGY OUTLOOK
4.1. Malaria Diagnostics Revenue Share (%) Analysis, by Technology Type, 2014 & 2022
4.2. Microscopy
4.2.1. Microscopy market revenue, 2012 to 2022 (USD Million)
4.2.2. Microscopy market volume, 2012 to 2022 (Million Units)
4.3. Rapid Diagnostic Tests (RDT)
4.3.1. Rapid diagnostic tests market revenue, 2012 to 2022 (USD Million)
4.3.2. Rapid diagnostic tests market volume, 2012 to 2022 (Million Units)
4.4. Others
4.4.1. Others market revenue, 2012 to 2022 (USD Million)
4.4.2. Others market volume, 2012 to 2022 (No. of Units)
CHAPTER 5. MALARIA DIAGNOSTICS REGIONAL OUTLOOK
5.1. Malaria Diagnostics Market Share (%) Analysis, by Region, 2014 & 2022
5.2. Africa
5.2.1. South Africa
5.2.1.1. South Africa malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.2.1.2. South Africa malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.2.2. Nigeria
5.2.2.1. Nigeria malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.2.2.2. Nigeria malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.2.3. Rest of Africa
5.2.3.1. Rest of Africa malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.2.3.2. Rest of Africa malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.3. South-East Asia
5.3.1. India
5.3.1.1. India malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.3.1.2. India malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.3.2. Rest of South-East Asia
5.3.2.1. Rest of South-East Asia malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.3.2.2. Rest of South-East Asia malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.4. Eastern Mediterranean
5.4.1. Saudi Arabia
5.4.1.1. Saudi Arabia malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.4.1.2. Saudi Arabia malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.4.2. Rest of Eastern Mediterranean
5.4.2.1. Rest of Eastern Mediterranean malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.4.2.2. Rest of Eastern Mediterranean malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.5. Europe
5.5.1. Turkey
5.5.1.1. Turkey malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.5.1.2. Turkey malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.5.2. Rest of Europe
5.5.2.1. Rest of Europe malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.5.2.2. Rest of Europe malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.6. Americas
5.6.1. Brazil
5.6.1.1. Brazil malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.6.1.2. Brazil malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.6.2. Mexico
5.6.2.1. Mexico malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.6.2.2. Mexico malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.6.3. Rest of Americas
5.6.3.1. Rest of Americas malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.6.3.2. Rest of Americas malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.7. Western Pacific
5.7.1. China
5.7.1.1. China malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.7.1.2. China malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.7.2. Rest of Western Pacific
5.7.2.1. Rest of Western Pacific malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.7.2.2. Rest of Western Pacific malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Access Bio Inc.
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. Alere Inc.
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Premier Medical Corporation Ltd.
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Sysmex Partec GmbH
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. bioM?rieux
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Beckman Coulter Inc.
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. Siemens Healthcare
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Leica Microsystems
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. Nikon Corporation
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives
6.10. Olympus Corporation
6.10.1. Company Overview
6.10.2. Financial Performance
6.10.3. Product Benchmarking
6.10.4. Strategic Initiatives
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Malaria Diagnostics Market - Industry Summary and Key Buying Criteria, 2012 - 2020
CHAPTER 3. MALARIA DIAGNOSTICS INDUSTRY OUTLOOK
3.1. Market segmentation
3.2. Market size and growth prospects, 2012-2020
3.3. Malaria Diagnostics: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing demand for diagnostic tools in malaria endemic countries
3.3.1.2. Development of technically advanced and efficient diagnostics
3.3.2. Market restraint analysis
3.3.2.1. Growth in countries moving towards malaria elimination phase
3.3.2.2. Rising demand for low cost diagnostic tools
3.4. Key opportunities prioritized
3.5. Malaria Diagnostics Industry analysis - Porter's Five Forces Model
3.6. Malaria Diagnostics Market - PESTEL Analysis
3.7. Malaria Diagnostics: Company Market Share Analysis (%), 2014
CHAPTER 4. MALARIA DIAGNOSTICS TECHNOLOGY OUTLOOK
4.1. Malaria Diagnostics Revenue Share (%) Analysis, by Technology Type, 2014 & 2022
4.2. Microscopy
4.2.1. Microscopy market revenue, 2012 to 2022 (USD Million)
4.2.2. Microscopy market volume, 2012 to 2022 (Million Units)
4.3. Rapid Diagnostic Tests (RDT)
4.3.1. Rapid diagnostic tests market revenue, 2012 to 2022 (USD Million)
4.3.2. Rapid diagnostic tests market volume, 2012 to 2022 (Million Units)
4.4. Others
4.4.1. Others market revenue, 2012 to 2022 (USD Million)
4.4.2. Others market volume, 2012 to 2022 (No. of Units)
CHAPTER 5. MALARIA DIAGNOSTICS REGIONAL OUTLOOK
5.1. Malaria Diagnostics Market Share (%) Analysis, by Region, 2014 & 2022
5.2. Africa
5.2.1. South Africa
5.2.1.1. South Africa malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.2.1.2. South Africa malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.2.2. Nigeria
5.2.2.1. Nigeria malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.2.2.2. Nigeria malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.2.3. Rest of Africa
5.2.3.1. Rest of Africa malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.2.3.2. Rest of Africa malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.3. South-East Asia
5.3.1. India
5.3.1.1. India malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.3.1.2. India malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.3.2. Rest of South-East Asia
5.3.2.1. Rest of South-East Asia malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.3.2.2. Rest of South-East Asia malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.4. Eastern Mediterranean
5.4.1. Saudi Arabia
5.4.1.1. Saudi Arabia malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.4.1.2. Saudi Arabia malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.4.2. Rest of Eastern Mediterranean
5.4.2.1. Rest of Eastern Mediterranean malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.4.2.2. Rest of Eastern Mediterranean malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.5. Europe
5.5.1. Turkey
5.5.1.1. Turkey malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.5.1.2. Turkey malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.5.2. Rest of Europe
5.5.2.1. Rest of Europe malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.5.2.2. Rest of Europe malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.6. Americas
5.6.1. Brazil
5.6.1.1. Brazil malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.6.1.2. Brazil malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.6.2. Mexico
5.6.2.1. Mexico malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.6.2.2. Mexico malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.6.3. Rest of Americas
5.6.3.1. Rest of Americas malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.6.3.2. Rest of Americas malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.7. Western Pacific
5.7.1. China
5.7.1.1. China malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.7.1.2. China malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
5.7.2. Rest of Western Pacific
5.7.2.1. Rest of Western Pacific malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
5.7.2.2. Rest of Western Pacific malaria diagnostics market, by technology, 2012 - 2022 (Million Units)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Access Bio Inc.
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. Alere Inc.
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Premier Medical Corporation Ltd.
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Sysmex Partec GmbH
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. bioM?rieux
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Beckman Coulter Inc.
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. Siemens Healthcare
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Leica Microsystems
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. Nikon Corporation
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives
6.10. Olympus Corporation
6.10.1. Company Overview
6.10.2. Financial Performance
6.10.3. Product Benchmarking
6.10.4. Strategic Initiatives
